Mariana Oncology to be Acquired by Novartis to Advance Precision Radiopharmaceuticals to Treat Cancer
Mariana Oncology a fully integrated biotechnology company pioneering a new era of radiopharmaceutical innovation to treat people with cancer today announced it will be acquired by Novartis for 1 billion upfront and up to 750 million in potential milestone payments.
United States Chris Brinzey Goodwin Procter Biomedical Research At Novartis Atlas Venture Centerview Partners
Source: businesswireindia.com